Table: SymBio Pharmaceuticals -Q1 group results

SymBio Pharmaceuticals

27/04/2023 07:30

Apr 27 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to  
                  Mar 31, 2023        Mar 31, 2022      Dec 31, 2023 
                     LATEST             YEAR-AGO           LATEST    
                     RESULTS             RESULTS          FORECAST   
  Sales               1.54                2.32              7.00     
                   (-33.3 pct)                          (-30.1 pct)  
  Operating          51 mln              509 mln        loss 331 mln 
                   (-89.9 pct)                                       
  Recurring          48 mln              478 mln        loss 351 mln 
                   (-89.9 pct)                                       
  Net                 4 mln              163 mln        loss 370 mln 
                   (-97.3 pct)                                       
  EPS               0.11 yen            4.25 yen       loss 9.48 yen 
  EPS Diluted       0.11 yen            4.18 yen                     
  Ann Div                                  NIL              NIL      
  -Q2 div                                  NIL              NIL      
  -Q4 div                                  NIL              NIL      
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T